Treatment of Chronic Hepatitis C in Young Children Reduces Adverse Outcomes and Is Cost-Effective Compared to Deferring Treatment to Adulthood

To evaluate the cost-effectiveness of treating young children with chronic hepatitis C virus (HCV) with new direct acting antivirals (DAAs).
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Original Articles Source Type: research